1. TCH346 as a neuroprotective drug in Parkinson's disease: a double-blind, randomised, controlled trial;Olanow;Lancet Neurol,2006
2. Recent clinical failures in Parkinson's disease with apoptosis inhibitors underline the need for a paradigm shift in drug discovery for neurodegenerative diseases;Waldmeier;Biochem Pharmacol,2006
3. Effect of deprenyl on the progression of disability in early Parkinson's disease;N Engl J Med,1989
4. CEP-1347 treatment fails to favorably modify the progression of Parkinson's disease (PRECEPT) study;Shoulson;Neurology,2006
5. A 2-year, multicenter, placebo-controlled, double-blind, parallel-group study of the effect of riluzole on Parkinson's disease progression;Rascol;Mov Disord,2002